Albumin-Bound Paclitaxel /nab-Paclitaxel
Sponsors
National Health Research Institutes, Taiwan, Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University, Eye & ENT Hospital of Fudan University, Cancer Institute and Hospital, Chinese Academy of Medical Sciences, Shanghai Pulmonary Hospital, Shanghai, China
Conditions
Biliary CancersBiliary Tract NeoplasmsCervical CancerExtensive Stage Small Cell Lung Cancer (ES-SCLC)Fallopian Tube CancersGastric Cancer in SituHead & Neck CancerHead and Neck Squamous Cell Carcinoma
Phase 1
Phase 2
Induction Chemotherapy Plus Cadonilimab for Locally Advanced Cervical Cancer
Active, not recruitingNCT06511726
Start: 2024-01-23End: 2029-04-30Target: 29Updated: 2026-06-04
Neoadjuvant Chemotherapy Combined With Finotonlimab in the Treatment of Locally Advanced Hypopharyngeal Carcinoma
RecruitingNCT07248956
Start: 2025-12-22End: 2029-12-30Target: 116Updated: 2025-12-23
Neoadjuvant Aitua (PD-1/CTLA-4 Bispecific) Plus Nab-Paclitaxel and Carboplatin for Advanced High-Grade Serous Ovarian Cancer
Not yet recruitingNCT07432594
Start: 2026-03-01End: 2027-06-30Target: 82Updated: 2026-02-25
Nab-Paclitaxel Combined With Local Therapy in Relapsed SCLC
Not yet recruitingNCT07547332
Start: 2026-04-06End: 2030-12-31Target: 84Updated: 2026-04-23
Nimotuzumab Combined With Immunotherapy and Chemotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
RecruitingNCT07601737
Start: 2026-04-20End: 2030-04-30Target: 182Updated: 2026-07-09
Exploratory Clinical Study of Camrelizumab Combined With Concurrent Chemoradiotherapy as an Organ-preserving Strategy for Locally Advanced Resectable Esophageal Squamous Cell Carcinoma
RecruitingNCT07622797
Start: 2025-11-21End: 2030-12-31Target: 164Updated: 2026-06-03
An Open-label, Single-arm, Multicenter Exploratory Study of Adebrelimab Combined With Gemcitabine and Albumin-bound Paclitaxel as First-line Treatment for Biliary Tract Malignancies
RecruitingNCT07668453
Start: 2025-10-20End: 2027-12-31Target: 30Updated: 2026-06-25